Implicating PARP and NAD+ depletion in type I diabetes
- 1 March 1999
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 5 (3), 269-270
- https://doi.org/10.1038/6479
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocinNature Medicine, 1999
- Apoptosis and the pathogenesis of IDDM: a question of life and death.Diabetes, 1998
- Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemiaNature Medicine, 1997
- Metabolic Fate of Glucose in Purified Islet CellsPublished by Elsevier BV ,1997
- Inactivation of the Poly(ADP-ribose) Polymerase Gene Affects Oxygen Radical and Nitric Oxide Toxicity in Islet CellsPublished by Elsevier BV ,1995
- STZ Transport and Cytotoxicity: Specific Enhancement in GLUT2-Expressing CellsDiabetes, 1994
- Biochemical Evidence for Nitric Oxide Formation from Streptozotocin in Isolated Pancreatic IsletsBiochemical and Biophysical Research Communications, 1993
- Interleukin-1β induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic isletsBiochemical and Biophysical Research Communications, 1992
- Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) MiceDiabetes, 1982
- Streptozotocin and alloxan induce DNA strand breaks and poly(ADP–ribose) synthetase in pancreatic isletsNature, 1981